Mostrar el registro sencillo del ítem
dc.contributor.author
Aarntzen, Erik H. J. G.
dc.contributor.author
Srinivas, Mangala
dc.contributor.author
Bonetto, Fernando Jose
dc.contributor.author
Cruz, Luis J.
dc.contributor.author
Verdijk, Pauline
dc.contributor.author
Schreibelt, Gerty
dc.contributor.author
Van de Rakt, Mandy
dc.contributor.author
Lesterhuis, W. Joost
dc.contributor.author
Van Riel, Maichel
dc.contributor.author
Punt, Cornelius J. A.
dc.contributor.author
Adema, Gosse J.
dc.contributor.author
Heerschap, Arend
dc.contributor.author
Figdor, Carl G.
dc.contributor.author
Oyen, Wim J.
dc.contributor.author
de Vries, I. Jolanda M.
dc.date.available
2015-09-23T18:51:20Z
dc.date.issued
2013-03-15
dc.identifier.citation
Aarntzen, Erik H. J. G.; Srinivas, Mangala; Bonetto, Fernando Jose; Cruz, Luis J.; Verdijk, Pauline; et al.; Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells; American Association for Cancer Research; Clinical Cancer Research; 19; 15-3-2013; 1525-1533
dc.identifier.issn
1078-0432
dc.identifier.uri
http://hdl.handle.net/11336/2073
dc.description.abstract
Anti-cancer dendritic cell (DC) vaccines require the DC to relocate to lymph nodes (LN) to trigger immune responses. However, these migration rates are typically very poor. Improving the targeting of ex vivo generated DC to LN might increase vaccine efficacy and reduce costs. We investigated DC migration in vivo in humans in different conditions.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
American Association for Cancer Research
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Dendritic Cells
dc.subject
19f Magnetic Resonance Imaging
dc.subject
Migration
dc.subject
Immunotherapy
dc.subject.classification
Oncología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.subject.classification
Radiología, Medicina Nuclear y Diagnóstico por Imágenes
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2016-03-30 10:35:44.97925-03
dc.journal.volume
19
dc.journal.pagination
1525-1533
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Philadelphia
dc.description.fil
Fil: Aarntzen, Erik H. J. G.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; Leiden University. Department of Endocrinology; Países Bajos;
dc.description.fil
Fil: Srinivas, Mangala. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.description.fil
Fil: Bonetto, Fernando Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET- Santa Fe. Instituto de Desarrollo Tecnológico para la Industria Química (i); Argentina;
dc.description.fil
Fil: Cruz, Luis J.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; Leiden University. Department of Endocrinology; Países Bajos;
dc.description.fil
Fil: Verdijk, Pauline. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos; National Institute for Public Health and the Environment. Departament of Vaccinology; Países Bajos;
dc.description.fil
Fil: Schreibelt, Gerty. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.description.fil
Fil: Van de Rakt, Mandy. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.description.fil
Fil: Lesterhuis, W. Joost. Radboud University Nijmegen Medical Centre. Department of Medical Oncology ; Países Bajos;
dc.description.fil
Fil: Van Riel, Maichel. Radboud Universiteit Nijmegen Medical Centre Department of Nuclear Medicine; Países Bajos;
dc.description.fil
Fil: Punt, Cornelius J. A.. Academic Medical Centre. Department of Medical Oncology; Países Bajos;
dc.description.fil
Fil: Adema, Gosse J.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.description.fil
Fil: Heerschap, Arend. Radboud Universiteit Nijmegen. Department of Radiology; Países Bajos;
dc.description.fil
Fil: Figdor, Carl G.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.description.fil
Fil: Oyen, Wim J.. Leiden University. Department of Endocrinology; Países Bajos;
dc.description.fil
Fil: de Vries, I. Jolanda M.. Radboud University Nijmegen Medical Centre. Nijmegen Centre for Molecular Life Sciences. Department of Tumor Immunology; Países Bajos;
dc.journal.title
Clinical Cancer Research
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/doi:10.1158/1078-0432.CCR-12-1879
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://clincancerres.aacrjournals.org/content/19/6/1525.long
Archivos asociados
Tamaño:
1.103Mb
Formato:
PDF